Tilray

$8.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.68 (-9.24%) Today
+$1.52 (+22.75%) As of 9:19 AM UTC after-hours

Why Robinhood?

You can buy or sell Tilray and other stocks, options, and ETFs commission-free!

About TLRY

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment sales consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment sales consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada. The listed name for TLRY is Tilray, Inc. Class 2 Common Stock.

CEO
Brendan Kennedy
Employees
1,646
Headquarters
Nanaimo, British Columbia
Founded
2018
Market Cap
891.95M
Price-Earnings Ratio
Dividend Yield
Average Volume
24.58M
High Today
$7.35
Low Today
$6.66
Open Price
$7.34
Volume
37.55M
52 Week High
$22.95
52 Week Low
$2.43

Collections

Digestible Financial News

Jack Kramer & Nick Martell

Managing Editors of News & Snacks at Robinhood Financial LLC

TLRY Earnings

-$1.45
-$0.97
-$0.50
-$0.02
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
-$0.21 per share
Actual
-$0.02 per share

You May Also Like